Nancy Y Lee

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation
    Nancy Lee
    Department of Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 57:49-60. 2003
  2. ncbi request reprint Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy
    Michelle L Klem
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
    Int J Radiat Oncol Biol Phys 70:1100-7. 2008
  3. pmc Current and emerging treatment options for nasopharyngeal carcinoma
    Daniel E Spratt
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Onco Targets Ther 5:297-308. 2012
  4. ncbi request reprint Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Lancet Oncol 13:172-80. 2012
  5. pmc An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer
    Daniel Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Radiat Oncol 5:74. 2010
  6. pmc Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases
    Amita Shukla Dave
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BMC Med Phys 9:4. 2009
  7. pmc Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:2-13. 2008
  8. ncbi request reprint Intensity-modulated radiation therapy in head and neck cancers: an update
    Nancy Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Head Neck 29:387-400. 2007
  9. pmc Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225
    Nancy Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 22, New York, NY 10021, USA
    J Clin Oncol 27:3684-90. 2009
  10. ncbi request reprint Intensity-modulated radiation therapy in the treatment of head and neck cancer involving the base of the skull
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10016, USA
    Int J Radiat Oncol Biol Phys 69:S43-5. 2007

Detail Information

Publications106 found, 100 shown here

  1. ncbi request reprint Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation
    Nancy Lee
    Department of Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 57:49-60. 2003
    ....
  2. ncbi request reprint Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy
    Michelle L Klem
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
    Int J Radiat Oncol Biol Phys 70:1100-7. 2008
    ..With conventional techniques, significant toxicity can develop. Intensity-modulated radiotherapy (IMRT) has the potential to minimize the toxicity...
  3. pmc Current and emerging treatment options for nasopharyngeal carcinoma
    Daniel E Spratt
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Onco Targets Ther 5:297-308. 2012
    ..Advances in RT technique, timing of chemotherapy, biologically targeted agents, particle therapy, adaptive RT, and the incorporation of EBV DNA as a biomarker may aid in the current and future treatment of nasopharyngeal cancer...
  4. ncbi request reprint Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Lancet Oncol 13:172-80. 2012
    ..We aimed to improve the outcomes for locoregionally advanced nasopharyngeal carcinoma by testing the feasibility and safety of the addition of bevacizumab to chemoradiotherapy...
  5. pmc An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer
    Daniel Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Radiat Oncol 5:74. 2010
    ..Intensity modulated radiation therapy (IMRT) has been incorporated at several institutions for early stage laryngeal cancer (T1/T2N0M0), but its utility is controversial...
  6. pmc Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases
    Amita Shukla Dave
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BMC Med Phys 9:4. 2009
    ..Further validation of the Avg-AIF approach with a larger population and in multiple regions is desirable...
  7. pmc Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:2-13. 2008
    ....
  8. ncbi request reprint Intensity-modulated radiation therapy in head and neck cancers: an update
    Nancy Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Head Neck 29:387-400. 2007
    ..The results do confirm that IMRT does decrease xerostomia compared with conventional radiotherapy...
  9. pmc Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225
    Nancy Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 22, New York, NY 10021, USA
    J Clin Oncol 27:3684-90. 2009
    ..To investigate the feasibility of intensity-modulated radiation therapy (IMRT) with or without chemotherapy, and to assess toxicities, failure patterns, and survivals in patients with nasopharyngeal carcinoma (NPC)...
  10. ncbi request reprint Intensity-modulated radiation therapy in the treatment of head and neck cancer involving the base of the skull
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10016, USA
    Int J Radiat Oncol Biol Phys 69:S43-5. 2007
    ..In this case report, the author presents a case in which difficult decisions were made when treating a complex, locally advanced, T4 nasopharyngeal cancer that invaded the skull base...
  11. ncbi request reprint A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 66:966-74. 2006
    ..intensity-modulated radiotherapy (IMRT) in the setting of concurrent chemotherapy (CT) for locally advanced oropharyngeal carcinoma...
  12. pmc Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy
    Nancy Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 75:101-8. 2009
    ....
  13. ncbi request reprint Intensity-modulated radiation therapy
    N Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10022, USA
    J Surg Oncol 97:691-6. 2008
    ..Further studies are ongoing to investigate long-term clinical outcomes and toxicity...
  14. doi request reprint Treatment outcomes for patients with synovial sarcoma of the head and neck
    Nancy Lee
    Memorial Sloan Kettering Cancer Center, Department of Radiation Oncology, NY, USA
    Expert Rev Anticancer Ther 8:371-3. 2008
    ..This paper highlights the importance of a multidisciplinary approach in the treatment of this disease...
  15. ncbi request reprint Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer
    Nancy Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 68:1299-309. 2007
    ..The purpose of this article is to establish IMRT guidelines for head-and-neck cancer at a given institution...
  16. ncbi request reprint Salvage re-irradiation for recurrent head and neck cancer
    Nancy Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 68:731-40. 2007
    ..To present a retrospective review of treatment outcomes for recurrent head and neck (HN) cancer patients treated with re-irradiation (re-RT) at a single medical center...
  17. ncbi request reprint Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:459-68. 2007
    ..To perform a retrospective review of laryngeal/hypopharyngeal carcinomas treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT)...
  18. pmc Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET
    Jacobus F A Jansen
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Int J Radiat Oncol Biol Phys 82:299-307. 2012
    ..Additionally, pretreatment multimodality imaging was evaluated for its efficacy in predicting short-term response to treatment...
  19. ncbi request reprint Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience
    Fernando F de Arruda
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
    Int J Radiat Oncol Biol Phys 64:363-73. 2006
    ..To review the Memorial Sloan-Kettering Cancer Center's experience in using intensity-modulated radiation therapy (IMRT) for the treatment of oropharyngeal cancer...
  20. ncbi request reprint Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?
    Allen M Chen
    Department of Radiation Oncology, University of California, San Francisco UCSF Comprehensive Cancer Center, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 69:141-7. 2007
    ..To compare clinical outcomes of patients with carcinomas of the paranasal sinuses and nasal cavity according to decade of radiation treatment...
  21. doi request reprint Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer
    Ramesh Rengan
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 31:465-9. 2008
    ..To examine the long-term neck failure outcome in patients with advanced head and neck cancer treated on larynx/organ preservation protocols at Memorial Sloan-Kettering Cancer Center...
  22. doi request reprint A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer
    Matthew G Fury
    Department of Medicine, Head and Neck Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York Department of Medicine, Weill Cornell Medical College, New York, New York
    Int J Radiat Oncol Biol Phys 87:479-86. 2013
    ..Preclinically, inhibition of mTORC1 with everolimus sensitizes cancer cells to cisplatin and radiation...
  23. doi request reprint Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience
    Jeremy Setton
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 82:291-8. 2012
    ..To update the Memorial Sloan-Kettering Cancer Center's experience with intensity-modulated radiotherapy (IMRT) in the treatment of oropharyngeal cancer (OPC)...
  24. ncbi request reprint Radiotherapy after surgical resection for head and neck mucosal melanoma
    Abraham J Wu
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Am J Clin Oncol 33:281-5. 2010
    ..To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck...
  25. doi request reprint Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 72:763-9. 2008
    ..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy...
  26. doi request reprint Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes
    Benjamin H Lok
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 82:1851-7. 2012
    ..To analyze the effect of primary gross tumor volume (pGTV) and nodal gross tumor volume (nGTV) on treatment outcomes in patients treated with definitive intensity-modulated radiation therapy (IMRT) for oropharyngeal cancer (OPC)...
  27. doi request reprint Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer
    Seng Chuan Ong
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Nucl Med 49:532-40. 2008
    ..We investigated the clinical utility of 18F-FDG PET/CT in this setting...
  28. ncbi request reprint Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:1365-72. 2008
    ..To analyze the recent experience of patients with adenoid cystic carcinoma treated with radiation therapy at Memorial Sloan-Kettering Cancer Center...
  29. doi request reprint Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience
    Stephanie A Terezakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:795-801. 2009
    ..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
  30. pmc Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
    Amita Shukla-Dave
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 82:1837-44. 2012
    ..The goal of this study was to assess the prognostic value of pretreatment DCE-MRI in head and neck squamous cell carcinoma (HNSCC) patients with nodal disease undergoing chemoradiation therapy or surgery...
  31. doi request reprint Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience
    Kim Huang
    Department of Radiation Oncology, University of California San Francisco, San Francisco, California 94143 0226, USA
    Cancer 113:497-507. 2008
    ..Treatment outcomes for stage III and IV oropharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) and concurrent chemotherapy without prior surgical resection were reviewed...
  32. ncbi request reprint Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck
    Allen M Chen
    Department of Radiation Oncology, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 70:338-43. 2008
    ..To report the clinical outcome of patients treated with combined-modality approaches for sinonasal undifferentiated carcinoma (SNUC) of the head and neck...
  33. doi request reprint Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 81:e207-13. 2011
    ..However, the incidence of this complication with intensity-modulated radiation therapy (IMRT) and dental sequelae with this technique have not been fully elucidated...
  34. ncbi request reprint Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:1096-103. 2009
    ..To present our single-institution experience of intensity-modulated radiotherapy (IMRT) for oral cavity cancer...
  35. pmc Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases
    Jacobus F A Jansen
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 77:1403-10. 2010
    ....
  36. doi request reprint Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy
    Paul B Romesser
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 118:6072-8. 2012
    ....
  37. doi request reprint Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 115:2128-37. 2009
    ..The aim of the current study was to determine patterns of failure and adverse prognostic features...
  38. doi request reprint Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer
    Carlo Greco
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 31:439-45. 2008
    ..To quantify differences between the alternative methods of F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-based delineation of the gross tumor volume in patients with head and neck cancer...
  39. pmc Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer
    Wenli Wang
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 51:37-45. 2010
    ....
  40. ncbi request reprint Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:691-702. 2007
    ..To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center...
  41. ncbi request reprint Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results
    Dev R Puri
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Clin Oncol 28:415-23. 2005
    ..Early reports of improvement in tumor control with better side effect profiles versus conventional techniques are promising, but will need to be confirmed with longer follow-up...
  42. doi request reprint Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer
    Anuj Goenka
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Cancer 133:1214-21. 2013
    ..We conclude that patients achieving CRs after chemoradiation, based on clinical and PET/CT assessment, have a high probability of regional control, with a 2.3% regional failure rate, and may be safely observed without planned ND...
  43. doi request reprint 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma
    Remy Lim
    Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Nucl Med 53:1506-13. 2012
    ..We investigated the prognostic value of staging (18)F-FDG PET/CT, beyond clinical risk factors, for predicting DM and OS in 176 patients after definitive chemoradiotherapy...
  44. pmc Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer
    Sadek A Nehmeh
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:235-42. 2008
    ..The aim of this study was to evaluate the reproducibility of (18)F-FMISO intratumor distribution using two pretreatment PET scans...
  45. ncbi request reprint The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron em
    Paul B Romesser
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Oral Oncol 50:802-8. 2014
    ....
  46. doi request reprint A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer
    Matthew G Fury
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 118:5008-14. 2012
    ..HNSCC tumors that express high levels of vascular endothelial growth factor have been associated with a worse prognosis, and bevacizumab may sensitize tumors to cisplatin and radiation...
  47. ncbi request reprint Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer
    Donald M Cannon
    Weill Cornell Medical College, New York, NY, USA
    Int J Radiat Oncol Biol Phys 70:660-5. 2008
    ..To discuss the implications of three examples of periparotid recurrence after definitive intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC)...
  48. doi request reprint Dosimetric distribution to the tooth-bearing regions of the mandible following intensity-modulated radiation therapy for base of tongue cancer
    Heidi J Hansen
    Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol 114:e50-4. 2012
    ..The purpose of this study was to determine the intensity-modulated radiation therapy (IMRT) dosages delivered to the tooth-bearing regions of the mandible...
  49. ncbi request reprint Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric analysis incorporating quality assurance guidelines from RTOG 0225
    Allen M Chen
    Departments of Radiation Oncology, University of California Davis Cancer Center, 4501 X Street, Suite G140, Sacramento, CA, USA
    Technol Cancer Res Treat 9:291-8. 2010
    ..02), larynx (p = 0.03), and oral cavity (p = 0.03). These findings suggest that HT-IMRT may be of improve the therapeutic ratio in the radiotherapeutic treatment of nasopharyngeal carcinoma...
  50. doi request reprint Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy
    Lawrence Koutcher
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 76:130-7. 2010
    ..To determine survival rates of patients with locally recurrent nasopharynx cancer (LRNPC) treated with modern therapeutic modalities...
  51. ncbi request reprint Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma
    David Huang
    Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 56:158-68. 2003
    ..To compare intensity-modulated radiotherapy (IMRT) treatment planning with three-dimensional conformal radiotherapy (3D-CRT) planning for paranasal sinus carcinoma...
  52. ncbi request reprint External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer
    Paul B Romesser
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
    J Surg Oncol 110:375-82. 2014
    ..To review clinical outcomes and toxicities in locally advanced differentiated thyroid cancer patients treated with external beam radiotherapy (EBRT) with or without concurrent chemotherapy (CCRT)...
  53. pmc Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy
    Daniel E Spratt
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 22, New York, New York 10021, USA
    Oncologist 17:569-76. 2012
    ..Cancer-related fatigue (CRF) is a highly prevalent and underestimated symptom in cancer patients. This study aims to analyze CRF solely in a cohort of oropharyngeal cancer patients who underwent treatment with radiotherapy (RT)...
  54. doi request reprint Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    JAMA Otolaryngol Head Neck Surg 139:1151-5. 2013
    ..Traditional prognostic models for squamous cell carcinoma of the head and neck are based on the TNM staging system. However, there is growing evidence that tumor volume (TV) may be a more accurate predictor of outcome...
  55. ncbi request reprint Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review
    Eric J Sherman
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States
    Radiother Oncol 101:425-30. 2011
    ..We evaluated our more recent experience with this approach, which included pathologic confirmation of all cases...
  56. doi request reprint Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much?
    Allen M Chen
    Department of Radiation Oncology, University of California, Davis Cancer Center, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 81:1211-9. 2011
    ..Numerous questions remain unanswered, and practical guidelines for clinical decision-making are sparse...
  57. pmc Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging
    Wenli Wang
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Phys Med Biol 54:3083-99. 2009
    ....
  58. ncbi request reprint Using an onboard kilovoltage imager to measure setup deviation in intensity-modulated radiation therapy for head-and-neck patients
    James G Mechalakos
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Appl Clin Med Phys 8:2439. 2007
    ..Nonzero systematic errors were seen in the interfractional translational and rotational data, but not in the intrafractional data, indicating that the mask is better at maintaining head position than at reproducing it...
  59. ncbi request reprint A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system
    Ping Xia
    Department of Radiation Oncology, University of California, San Francisco, 94143 1708, USA
    Int J Radiat Oncol Biol Phys 59:886-96. 2004
    ..The purpose of this study was to develop and test planning dose constraint templates for tumor and normal structures in the treatment of nasopharyngeal carcinoma (NPC) using a specific commercial inverse treatment planning system...
  60. ncbi request reprint Predictors of outcome for advanced-stage supraglottic laryngeal cancer
    Ian Ganly
    Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Head Neck 31:1489-95. 2009
    ..The objective of this study was to report our experience in the management of patients with advanced-stage supraglottic laryngeal carcinoma and to identify factors predictive of outcome...
  61. ncbi request reprint Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Jay S Cooper
    New York University Medical Center, New York, USA
    N Engl J Med 350:1937-44. 2004
    ..We tested the hypothesis that concurrent postoperative administration of cisplatin and radiotherapy would improve the rate of local and regional control...
  62. ncbi request reprint Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10021, USA
    Head Neck 30:925-32. 2008
    ....
  63. ncbi request reprint High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results
    Ashwatha Narayana
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Brachytherapy 6:157-63. 2007
    ..We report our preliminary results in patients with recurrent H&N cancers treated with interstitial HDRBT...
  64. doi request reprint Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience
    Tihana Ibrahimpasić
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Thyroid 23:997-1002. 2013
    ..To describe the outcome of patients with poorly differentiated thyroid cancer (PDTC) presenting with gross extrathyroidal extension (ETE)...
  65. doi request reprint High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer
    Sewit Teckie
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY10065, USA
    Brachytherapy 12:228-34. 2013
    ..To report long-term outcomes of high-dose-rate (HDR) intraoperative radiotherapy (IORT) at the time of radical resection for recurrent head-and-neck cancer and determine potential prognostic factors...
  66. pmc The abscopal effect associated with a systemic anti-melanoma immune response
    Emily F Stamell
    Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
    Int J Radiat Oncol Biol Phys 85:293-5. 2013
    ..This case supports the immune hypothesis for the abscopal effect, and illustrates the potential of combining radiotherapy and immunotherapy in the treatment of melanoma...
  67. doi request reprint Concurrent chemotherapy and radiotherapy for head and neck cancer
    Ryan J Burri
    Mount Sinai School of Medicine, Department of Radiation Oncology, One Gustave L Levy Place, Box 1236, New York, NY 10029, USA
    Expert Rev Anticancer Ther 9:293-302. 2009
    ..This article focuses on the rationale and evidence supporting the use of concurrent chemotherapy and radiation therapy in the management of locally advanced head and neck cancers...
  68. doi request reprint High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer
    David J Perry
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 76:1140-6. 2010
    ..To report the use of high-dose-rate intraoperative radiation therapy (HDR-IORT) for recurrent head-and-neck cancer (HNC) at a single institution...
  69. ncbi request reprint Advances in nasopharyngeal carcinoma
    William P O'Meara
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Curr Opin Oncol 17:225-30. 2005
    ..This review highlights recent advances in the management of nasopharyngeal carcinoma as a result of these endeavors...
  70. ncbi request reprint A nomogram to predict loco-regional control after re-irradiation for head and neck cancer
    Nadeem Riaz
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, United States
    Radiother Oncol 111:382-7. 2014
    ..The role of re-irradiation (re-RT) remains unclear due to toxicity. We determined prognostic factors for loco-regional control (LRC) and formulated a nomogram to help clinicians select re-RT candidates...
  71. doi request reprint Decision making in the management of recurrent head and neck cancer
    Allen S Ho
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    Head Neck 36:144-51. 2014
    ..The decision for salvage therapy must be individualized, with management that involves well-informed patients resulting in the best outcomes...
  72. ncbi request reprint Intensity-modulated radiation therapy for head and neck cancer
    William W Chou
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY 10021, USA
    Expert Rev Anticancer Ther 5:515-21. 2005
    ....
  73. doi request reprint Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer
    Wei Hsien Hou
    Department of Radiation Oncology, University of California, Davis School of Medicine, Sacramento, USA
    Arch Otolaryngol Head Neck Surg 138:644-9. 2012
    ..To identify potential racial disparities in the use of larynx preservation...
  74. pmc New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Semin Oncol 35:236-50. 2008
    ..The second half of the review will focus on approaches for assessing tumor hypoxia and on the strategies for targeting this important microenvironmental factor in HNC...
  75. pmc Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients
    Vikram D Kekatpure
    Department of Medicine, Weill Cornell Medical College, New York, New York 10065, USA
    Cancer Prev Res (Phila) 2:957-65. 2009
    ..Possibly, HNSCC patients with high COX-2 activity manifested by elevated urinary PGE-M will benefit from treatment with a COX-2 inhibitor...
  76. ncbi request reprint Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer
    Benjamin D Rosenbluth
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 63:1419-26. 2005
    ..Intensity-modulated radiation therapy (IMRT) enables highly conformal treatment for thyroid cancer (TC). In this study, we review outcomes/toxicity in a series of TC patients treated with IMRT...
  77. doi request reprint Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer
    William H Hall
    Department of Radiation Oncology, University of California, Davis, Cancer Center, Sacramento, CA, USA
    Int J Radiat Oncol Biol Phys 72:1362-7. 2008
    ....
  78. ncbi request reprint Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose
    Clinton S Park
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143 7108, USA
    Int J Radiat Oncol Biol Phys 62:925-32. 2005
    ....
  79. ncbi request reprint Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx
    Ian Ganly
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Arch Otolaryngol Head Neck Surg 132:59-66. 2006
    ..To report the outcome of surgical salvage performed for early-stage squamous cell carcinoma of the glottic larynx that recurred or progressed after definitive radiotherapy...
  80. pmc Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial
    David G Pfister
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 28:2565-70. 2010
    ..To determine whether acupuncture reduces pain and dysfunction in patients with cancer with a history of neck dissection. The secondary objective is to determine whether acupuncture relieves dry mouth in this population...
  81. ncbi request reprint Oral cavity and oropharynx tumors
    Hilda E Stambuk
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiol Clin North Am 45:1-20. 2007
    ....
  82. ncbi request reprint Geometric factors influencing dosimetric sparing of the parotid glands using IMRT
    Margie A Hunt
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 66:296-304. 2006
    ..To determine the relationship between the parotid volume, parotid-planning target volume (PTV) overlap, and dosimetric sparing of the parotid with intensity-modulated radiation therapy (IMRT)...
  83. ncbi request reprint Simplifying intensity-modulated radiotherapy plans with fewer beam angles for the treatment of oropharyngeal carcinoma
    Robert Takamiya
    Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA
    J Appl Clin Med Phys 8:26-36. 2007
    ..However, the improved efficiency does not significantly reduce the total number of MUs nor the indirect radiation dose...
  84. doi request reprint PET monitoring of therapy response in head and neck squamous cell carcinoma
    Heiko Schoder
    Department of Radiology, Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Nucl Med 50:74S-88S. 2009
    ....
  85. pmc The effect of significant tumor reduction on the dose distribution in intensity modulated radiation therapy for head-and-neck cancer: a case study
    James Mechalakos
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Med Dosim 34:250-5. 2009
    ..In the IGRT era, delivered dose distributions can be more readily determined during treatment, and this information can be useful in deciding whether replanning is necessary...
  86. pmc Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer
    Joseph A O'Donoghue
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    EJNMMI Res 3:42. 2013
    ....
  87. doi request reprint Radiation therapy for cutaneous melanoma
    Christopher A Barker
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Dermatol Clin 30:525-33. 2012
    ..Optimal care of melanoma patients involves radiation therapy; awareness of this is incumbent of clinicians caring for patients with this disease...
  88. doi request reprint Fistula formation after postoperative radiation treatment for paranasal sinus cancer
    Stephanie A Terezakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Am J Clin Oncol 31:199-204. 2008
    ..This report describes the clinical scenario and management of the rare incidence of fistula formation after radiation for paranasal sinus malignancy...
  89. ncbi request reprint A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer
    R Michael Tuttle
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer Control 18:89-95. 2011
    ....
  90. ncbi request reprint A forward-planned treatment technique using multisegments in the treatment of head-and-neck cancer
    Nancy Lee
    Department of Radiation Oncology, University of California San Francisco Medical Center, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 59:584-94. 2004
    ....
  91. doi request reprint Head-and-neck target delineation among radiation oncology residents after a teaching intervention: a prospective, blinded pilot study
    Justin E Bekelman
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 73:416-23. 2009
    ....
  92. ncbi request reprint Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull
    Nancy Lee
    Department of Radiation Oncology, University of California San Francisco, 505 Parnassus Ave, L 08 Box 0226, San Francisco, California 94143 0226, USA
    Head Neck 25:210-6. 2003
    ..The management of skull base recurrence of salivary gland tumors is challenging, because complete surgical resection and fractionated reirradiation are seldom possible. Experience is being gained with radiosurgery for this indication...
  93. ncbi request reprint Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation?
    Allen M Chen
    Department of Radiation Oncology, University of California, San Francisco UCSF Comprehensive Cancer Center, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 67:988-94. 2007
    ..To evaluate the incidence of nodal relapses from carcinomas of the salivary glands among patients with clinically negative necks in an attempt to determine the potential utility of elective neck irradiation (ENI)...
  94. ncbi request reprint Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients
    Charles Scarantino
    Department of Radiation Oncology, Rex Cancer Center, Raleigh, North Carolina 27607, USA
    J Support Oncol 4:252-8. 2006
    ..However, the absent correlation between improved salivary flow and QOL scores is of some concern (though not a new finding) and may be related to the existence of comorbidities and the lack of effect on mucositis...
  95. ncbi request reprint Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
    Nancy Lee
    Department of Radiation Oncology, University of California San Francisco, 505 Parnassus Avenue, L 08, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 53:12-22. 2002
    ..To update our experience with intensity-modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma (NPC)...
  96. ncbi request reprint Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma
    Nancy Lee
    Department of Radiation Oncology, Medical Center, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 53:630-7. 2002
    ..To investigate the cause of acute skin toxicity observed in the treatment of head-and-neck cancer with extended-field intensity-modulated radiotherapy (EF-IMRT)...
  97. ncbi request reprint The role of external beam radiotherapy in the treatment of papillary thyroid cancer
    Nancy Lee
    Radiation Oncology and Endocrine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Endocr Relat Cancer 13:971-7. 2006
    ..In this commentary, these issues will be discussed and recommendations regarding the role of EBRT will be given...
  98. ncbi request reprint Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience
    Nancy Lee
    Department of Radiation Oncology, University of California San Francisco, San Francisco, CA 94143, USA
    Brachytherapy 1:74-82. 2002
    ..The local control, distant metastasis-free rate, overall survival, and morbidity are presented...
  99. doi request reprint Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses
    Ziv Gil
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Arch Otolaryngol Head Neck Surg 135:173-9. 2009
    ..To characterize the incidence and pattern of neural invasion (NI) in patients with cancers of the paranasal sinuses and anterior skull base...
  100. doi request reprint The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient
    Aleksandra Raykher
    Department of Medicine, Columbia University College of Physician and Surgeons, New York, New York, USA
    JPEN J Parenter Enteral Nutr 33:404-10. 2009
    ..Percutaneous endoscopic gastrostomy (PEG) feedings bypass the oropharynx, allowing administration of nutrients and medications into the stomach, thus preventing malnutrition, dehydration, and treatment interruption...
  101. ncbi request reprint Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation
    Theresa A Gurney
    Department of Otolaryngology Head and Neck Surgery, University of California San Francisco, San Francisco, California 94143, USA
    Laryngoscope 115:1278-82. 2005
    ..To examine patient characteristics, pathologic features, and treatment outcomes of adenoid cystic carcinoma of the major salivary glands...